APA (7th ed.) Citation

Bidar, F., Hamada, S., Gossez, M., Coudereau, R., Lopez, J., Cazalis, M., . . . Garnier, L. (2022). Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients. Annals of Intensive Care, 12(1), 1. https://doi.org/10.1186/s13613-022-01007-7

Chicago Style (17th ed.) Citation

Bidar, Frank, et al. "Correction to: Recombinant Human Interleukin-7 Reverses T Cell Exhaustion Ex Vivo in Critically Ill COVID-19 Patients." Annals of Intensive Care 12, no. 1 (2022): 1. https://doi.org/10.1186/s13613-022-01007-7.

MLA (9th ed.) Citation

Bidar, Frank, et al. "Correction to: Recombinant Human Interleukin-7 Reverses T Cell Exhaustion Ex Vivo in Critically Ill COVID-19 Patients." Annals of Intensive Care, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1186/s13613-022-01007-7.